Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: Association with treatment of rejection

Journal of Hepatology

Volumn 28, Issue 5, 1998, Pages 756-763

  Berenguer, Marina ^a   Prieto, Martín ^a   Córdoba, Juan ^a   Rayón, José Miguel ^a   Carrasco, Domingo ^a   Olaso, Vicente ^a   San Juan, Fernando ^a   Gobernado, Miguel ^a   Mir, José ^a   Berenguer, Joaquín ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Hepatitis C virus; Immunosuppression; Liver transplantation; Rejection

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; OKT 3; PREDNISOLONE; PREDNISONE;

ADULT; AGED; ARTICLE; CHRONIC ACTIVE HEPATITIS; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; RECURRENT INFECTION; RETROSPECTIVE STUDY; VIRUS INFECTION;

EID: 0032080213     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80224-9     Document Type: Article

References (30)

1. Wright TL, Donegan E, Hsu H, Ferrell L, Lake J, Kim M, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 103:1992;317-322.
2. Feray C, Samuel D, Thiers V, Gigou M, Pichon F, Bismuth A, et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest. 89:1992;1361-1365.
3. Ferrell L, Wright T, Roberts J, Ascher N, Lake JR. Hepatitis C viral infection in liver transplant recipients. Hepatology. 16:1992;865-876.
4. Ascher NL, Lake JR, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology. 20:1994;24-27. (Suppl).
5. König V, Bauditz J, Lobeck H, Lüsebrink R, Neuhaus P, Blumhart G, et al. Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology. 16:1992;1137-1143.
6. Shah G, Demetris AJ, Gavaler JS, Lewis JH, Todo S, Starzl TE, et al. Incidence, prevalence and clinical course of hepatitis C following liver transplantation. Gastroenterology. 103:1992;323-329.
7. Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, et al. The course of hepatitis C infection after liver transplantation. Hepatology. 20:1994;1137-1143.
8. Casavilla A, Mateo R, Rakela J, Demetris AJ, Starzl TE, Irish W, et al. Impact of hepatitis C virus (HCV) infection on survival following primary liver transplantation (OLTx) under FK506 [abstract]. Hepatology. 20:1994;133.
9. Gane E, Portmann B, Naoumov N, Smith H, Underhill J, Donaldson P, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 334:1996;815-820.
10. Davies SE, Portmann BC, O'Grady JG, Aldis PM, Chaggar K, Alexander GJM, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology. 13:1989;150-157.
11. Schluger L, Sheiner P, Thung S, Lau J, Min A, Wolf D, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology. 23:1996;971-976.
12. Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens C, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology. 108:1995;1088-1096.
13. Gane E, Naoumov N, Qian K, Mondelli M, Maertens G, Portmann B, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology. 110:1996;167-177.
14. Shuan Z, Terrault N, Ferrell L, Hahn J, Lau JYN, Simmonds P, et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology. 24:1996;1041-1046.
15. Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology. 106:1994;994-999.
16. Freeman R, Tran S, Lee Y, Rohrer R, Kaplan M. Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis. Transplantation. 61:1996;542-546.
17. Berenguer M, Terrault NA, Piatak M, Yun A, Kim JP, Lau J, et al. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology. 111:1996;1569-1575.
18. Huang E, Wright TL, Lake J, Combs C, Ferrell L. Hepatitis B and C coinfections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation. Hepatology. 23:1996;396-404.
19. Sheiner P, Schwartz M, Mor E, Schluger L, Theise N, Kishikawa K, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology. 21:1995;30-34.
20. Demetris AJ, Shiquang Q, Hong S, Fung JJ. Liver allograft rejection: an overview of morphologic findings. Am J Surg Pathol. 14:1990;49-63.
21. De Groote J, Desmet VJ, Gedigk P, Popper H, Sheuer PJ, Thaler N, et al. A classification of chronic hepatitis. Lancet. ii:1968;626-628.
22. Zachary DG, Ishak KG. Histopathology of hepatitis C virus infection. Semin Liver Dis. 15:1995;70-81.
23. Prieto M, Olaso V, Verdú C, Córdoba J, Gisbert C, Rayón M, et al. Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction. Hepatology. 22:1995;413-417.
24. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol. 74:1993;1093-1102.
25. Chomcynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
26. Fong TL, Valinluck B, Govindarajan S, Charboneau F, Adkins RH, Redeker AG. Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology. 107:1994;196-199.
27. Vento S, Cainelli F, Mirandola F, Cosco L, Perri G, Solbiati M, et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet. 347:1996;92-93.
28. Gruber A, Lundberg LG, Björkholm M. Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy. J Intern Med. 234:1993;223-225.
29. Fan FS, Tzeng CH, Hsiao KI, Hu ST, Liu WT, Chen PM. Withdrawal of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C. Bone Marrow Transplant. 8:1991;417-420.
30. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med. 327:1992;1899-1905.